Trump admin buys almost entire world stock of remdesivir
 

NEW YORK: The Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key COVID-19 drug for the rest of the world, foreign media reported.As a result of an agreement...http://feeds.feedburner.com/~r/com/cwEr/~4/oEF9zyIbNNs

أكثر...